We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Effect of Clopidogrel on Arteriovenous Fistulas for Dialysis

Costas Fourtounas, MD, PhD; Jannis G. Vlachojannis, MD
JAMA. 2008;300(14):1647-1649. doi:10.1001/jama.300.14.1648-a.
Text Size: A A A
Published online


To the Editor: The trial by Dr Dember and colleagues1 failed to show any improvement in fistula maturation for hemodialysis by using clopidrogrel, although its use decreased the frequency of early thrombosis. However, the design of the study might explain some of the results.

Successful arteriovenous fistula creation depends on many important factors. First, there must be adequate predialysis care, particularly protection of the veins from unnecessary cannulations for blood sampling or for intravenous administration of fluids and medications; this was not described. Second, there must be appropriate preoperative evaluation of the arterial and venous networks by methods such as x-rays for possible detection of calcifications of the arteries, Doppler ultrasound for arteries and veins, or venography.2 Although Dember et al report that vascular mapping was performed in almost 75% of the patients,1 they do not provide extensive data. It would be interesting to explore whether mapping presented any advantage, provided that this approach was not biased by being used only in more complicated cases.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




October 8, 2008
Raghav Wusirika, MD; Panduranga Rao, MD, DNB, MS
JAMA. 2008;300(14):1647-1649. doi:10.1001/jama.300.14.1647-a.
October 8, 2008
Dirk M. Hentschel, MD; Arif Asif, MD
JAMA. 2008;300(14):1647-1649. doi:10.1001/jama.300.14.1647-b.
October 8, 2008
Laura M. Dember, MD; Gerald J. Beck, PhD; Harold I. Feldman, MD, MSCE
JAMA. 2008;300(14):1647-1649. doi:10.1001/jama.300.14.1648-b.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.